NYSE American: MTNB

Matinas BioPharma Holdings, Inc. (MTNB)

Matinas BioPharma Holdings, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on NYSE American under the ticker MTNB. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
MTNB
Exchange
NYSE American
SEC CIK
1582554
Official filings
SEC EDGAR

Research MTNB

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Matinas BioPharma Holdings, Inc.'s stock ticker?

Matinas BioPharma Holdings, Inc. trades under the ticker symbol MTNB on NYSE American. Its SEC Central Index Key (CIK) is 1582554.

Where can I read Matinas BioPharma Holdings, Inc.'s SEC filings?

The MTNB SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Matinas BioPharma Holdings, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze MTNB's financial statements?

The MTNB Financials page shows Matinas BioPharma Holdings, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does MTNB compare with its peers and the market?

The MTNB Peer Comparison page lines Matinas BioPharma Holdings, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.